title: Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice.
abstract: We tested the ability of inactivated SARS-CoV vaccine to induce neutralizing antibodies in BALB/c mice. The inactivated vaccine was prepared by SARS-CoV virus propagation in Vero cells, with subsequent beta-propiolactone inactivation and Sepharose 4FF column chromatography purification. One hundred forty BALB/c female mice were divided into seven groups of 20 mice each. Of the seven groups, three groups were inoculated with 0.1, 1, and 3 microg of the vaccine without adjuvant while three other groups were inoculated at the same three dosages of vaccine with aluminum hydroxide as adjuvant, respectively. The remaining group was set up as a blank control. Each mouse was inoculated twice at an interval of 3 weeks. One week after the second immunization, mice sera were collected to detect serum neutralizing antibodies. An assay for determining neutralizing antibody titers was developed. The results can be summarized as follows: (1) higher dosages of vaccine induced higher levels of neutralizing antibody titer; (2) the level of neutralizing antibodies induced by the inoculation with aluminum hydroxide adjuvant was slightly higher than that without adjuvant, but the difference was not statistically significant.
authors.affiliation: Beijing Genomics Institute, Chinese Academy of Sciences, People's Republic of China.
authors.forename: Lin
authors.initials: L
authors.lastname: Tang
authors.forename: Qingyu
authors.initials: Q
authors.lastname: Zhu
authors.forename: Ede
authors.initials: E
authors.lastname: Qin
authors.forename: Man
authors.initials: M
authors.lastname: Yu
authors.forename: Zhifen
authors.initials: Z
authors.lastname: Ding
authors.forename: Huiying
authors.initials: H
authors.lastname: Shi
authors.forename: Xiaojie
authors.initials: X
authors.lastname: Cheng
authors.forename: Caiping
authors.initials: C
authors.lastname: Wang
authors.forename: Guohui
authors.initials: G
authors.lastname: Chang
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhu
authors.forename: Fang
authors.initials: F
authors.lastname: Fang
authors.forename: Haiyan
authors.initials: H
authors.lastname: Chang
authors.forename: Shuangli
authors.initials: S
authors.lastname: Li
authors.forename: Xumin
authors.initials: X
authors.lastname: Zhang
authors.forename: Xishu
authors.initials: X
authors.lastname: Chen
authors.forename: Jun
authors.initials: J
authors.lastname: Yu
authors.forename: Jian
authors.initials: J
authors.lastname: Wang
authors.forename: Ze
authors.initials: Z
authors.lastname: Chen
mesh_terms: D000536:Aluminum Hydroxide; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D002522:Chlorocebus aethiops; D002845:Chromatography; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007106:Immune Sera / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D011420:Propiolactone; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000276:immunology; D014709:Vero Cells; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007106:Immune Sera; D015164:Vaccines, Inactivated; D014765:Viral Vaccines; D000536:Aluminum Hydroxide; D011420:Propiolactone